Erasca (ERAS) Accumulated Expenses (2020 - 2026)
Erasca (ERAS) reported Accumulated Expenses of $19.2 million for Q1 2026, up 231.1% on a YoY basis from $5.8 million in Q1 2025, and down 14.31% quarter-over-quarter from $22.5 million in Q4 2025.
Erasca (ERAS) Accumulated Expenses (2020 - 2026) Analysis & Trends
Erasca has reported Accumulated Expenses for 7 years, with the latest figure at $19.2 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 231.1% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $19.2 million (up 231.1% YoY), and the FY2025 full-year result was $22.5 million, down 14.61% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $19.2 million, down from $22.5 million in the prior quarter.
- The five-year high for Accumulated Expenses was $26.3 million in Q4 2024, with the low at $178000.0 in Q1 2024.
- Historically, Accumulated Expenses has averaged $12.7 million across 5 years, with a median of $8.5 million in 2023.
- Annual changes were most pronounced in 2024 — Accumulated Expenses tumbled 99.07% — and 2025, when it surged 3166.29%.
- Erasca's Accumulated Expenses stood at $24.3 million in 2022, then plunged by 57.63% to $10.3 million in 2023, then surged by 155.14% to $26.3 million in 2024, then dropped by 14.61% to $22.5 million in 2025, then retreated by 14.31% to $19.2 million in 2026.
- The last three Accumulated Expenses figures came in at $19.2 million (Q1 2026), $22.5 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.25 Mn |
| Dec 31, 2025 | 22.46 Mn |
| Sep 30, 2025 | 20.80 Mn |
| Jun 30, 2025 | 6.64 Mn |
| Mar 31, 2025 | 5.81 Mn |
| Dec 31, 2024 | 26.31 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 6.15 Mn |
| Mar 31, 2024 | 178,000.00 |
| Dec 31, 2023 | 10.31 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Mar 31, 2023 | 19.05 Mn |
| Dec 31, 2022 | 24.34 Mn |
| Sep 30, 2022 | 7.10 Mn |
| Jun 30, 2022 | 19.83 Mn |
| Mar 31, 2022 | 4.57 Mn |
| Dec 31, 2021 | 21.26 Mn |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 6.31 Mn |